CPT® Code 83012

1. Indications

The haptoglobin phenotype test is performed for several specific indications, particularly in the context of hemolytic conditions. The following are the primary indications for conducting this test:

• Intravascular Hemolytic Anemia - This condition involves the destruction of red blood cells within the blood vessels, leading to the release of free hemoglobin that haptoglobin binds to.
• Transfusion Reactions - Haptoglobin testing can help assess the body's response to blood transfusions, particularly in cases where hemolysis may occur.
• Autoimmune Hemolytic Anemia - In this condition, the immune system mistakenly attacks and destroys red blood cells, necessitating the evaluation of haptoglobin levels and phenotypes.
• Acute Inflammatory Reactions - The test may be indicated in situations where acute inflammation is suspected, as haptoglobin levels can be affected by inflammatory processes.

2. Procedure

The procedure for identifying haptoglobin phenotypes involves several key steps that ensure accurate results. The following outlines the procedural steps:

• Step 1: Blood Sample Collection - A blood sample is obtained from the patient through a venipuncture, which is a standard procedure for drawing blood. This sample is crucial for subsequent testing.
• Step 2: Serum or Plasma Preparation - Once the blood sample is collected, it is processed to separate the serum or plasma, which is necessary for the haptoglobin phenotype testing.
• Step 3: Testing Methodology - The serum or plasma is then subjected to quantitative immunoturbidimetric testing. This method allows for the precise measurement of haptoglobin levels and the identification of specific phenotypes.
• Step 4: Phenotype Identification - The test results will categorize the haptoglobin into one of the three main phenotypes: Hp 1-1, Hp 2-1, or Hp 2-2, based on their binding activity and response to free hemoglobin.

3. Post-Procedure

After the haptoglobin phenotype testing is completed, the results are analyzed and interpreted by healthcare professionals. Depending on the identified phenotype, further clinical evaluation may be warranted to assess the patient's susceptibility to specific conditions associated with each haptoglobin type. There are no specific post-procedure care requirements for patients following this test, as it is a routine blood test with minimal risk. However, healthcare providers may discuss the implications of the test results with the patient and recommend any necessary follow-up actions or additional testing based on the findings.